OPTISCAN IMAGING LIMITED(OIL.AU),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

OIL.AU OPTISCAN IMAGING LIMITED

Market Closed 11-22 16:12:00 AEDT

0.14

-0.02

-12.50%

High0.17	Low0.13	Vol462.57K
Open0.17	D1 Closing0.16	Amplitude21.88%
Mkt Cap116.95M	Tradable Cap58.33M	Total Shares835.34M
T/O67.72K	T/O Rate0.11%	Tradable Shares416.61M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"OIL.AU","market":"AU","secType":"STK","nameCN":"OPTISCAN IMAGING LIMITED","latestPrice":0.14,"timestamp":1732252320000,"preClose":0.16,"halted":0,"volume":462569,"delay":0,"nameEN":"OPTISCAN IMAGING LIMITED","floatShares":416609602,"shares":835340803,"eps":-0.007399,"marketStatus":"Market Closed","change":-0.02,"latestTime":"11-22 16:12:00 AEDT","open":0.165,"high":0.165,"low":0.13,"amount":67722,"amplitude":0.21875,"askPrice":0.165,"askSize":64050,"bidPrice":0.14,"bidSize":2355,"shortable":3,"etf":0,"ttmEps":-0.007399,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1732489200000},"marketStatusCode":7,"adr":0,"exchange":"ASX","adjPreClose":0.16,"openAndCloseTimeList":[[1732230000000,1732251600000]],"volumeRatio":9.524779279683688,"lotSize":1,"tradeCurrency":"AUD"},"requestUrl":"/m/hq/s/OIL.AU/tweets","defaultTab":"tweets","newsList":[{"id":"2484295636","title":"Optiscan Imaging Enters Research Agreement with US Veterinary College","url":"https://stock-news.laohu8.com/highlight/detail?id=2484295636","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484295636?lang=en_us&edition=fundamental","pubTime":"2024-11-19 10:22","pubTimestamp":1731982934,"startTime":"0","endTime":"0","summary":"Optiscan Imaging  entered a collaborative research agreement with the University of Minnesota College of Veterinary Medicine, according to a Monday filing with the Australian bourse.As part of the agreement, both parties will use the University's extensive research facilities to explore clinical applications of Optiscan Imaging's technology in veterinary medicine, the filing said.The research will focus initially on advancing the diagnosis and treatment of cancer in companion animals.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7007","OIL.AU"],"gpt_icon":0},{"id":"2480481342","title":"ASX Penny Stocks To Watch In November 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2480481342","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2480481342?lang=en_us&edition=fundamental","pubTime":"2024-11-04 12:08","pubTimestamp":1730693294,"startTime":"0","endTime":"0","summary":"As the ASX200 experiences a modest rise of 0.21% to 8,135 points, sector performance varies with Utilities leading gains and Energy lagging behind. In such a diverse market landscape, identifying promising investment opportunities requires careful consideration of financial health and growth potential. Penny stocks, often associated with smaller or newer companies, still offer intriguing possibilities for investors seeking value at lower price points; when these stocks are supported by strong fundamentals, they can present an opportunity for significant returns.Click here to see the full list of 1,033 stocks from our ASX Penny Stocks screener.We're going to check out a few of the best picks from our screener tool.Review our historical performance report to gain insights into Auctus Investment Group's track record.ASX:AVC Financial Position Analysis as at Nov 2024. Overview: Optiscan Imaging Limited develops, manufactures, and commercializes endomicroscopic digital imaging technology so","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/p9AmAMKjf.qGqvNo1JBhgQ--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/587bca1ec4acb3634ab3a458c085a4fc","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/p9AmAMKjf.qGqvNo1JBhgQ--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/587bca1ec4acb3634ab3a458c085a4fc"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/asx-penny-stocks-watch-november-040814835.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["BK7088","IGL.AU","BK7007","BK7502","ATP.AU","NGI.AU","BK7045","BK7062","EVO.AU","BK7077","BK7132","BK7095","LBL.AU","BK7107","BK7024","PRO.AU","BK7070","PRN.AU","HLO.AU","MXI.AU","OIL.AU","AVC.AU","ANG.AU","JYC.AU","BK7131"],"gpt_icon":0},{"id":"2475375424","title":"Investing in Optiscan Imaging (ASX:OIL) five years ago would have delivered you a 345% gain","url":"https://stock-news.laohu8.com/highlight/detail?id=2475375424","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2475375424?lang=en_us&edition=fundamental","pubTime":"2024-10-15 09:40","pubTimestamp":1728956423,"startTime":"0","endTime":"0","summary":"Optiscan Imaging Limited  shareholders might be concerned after seeing the share price drop 23% in the last quarter. But over five years returns have been remarkably great. To be precise, the stock price is 336% higher than it was five years ago, a wonderful performance by any measure. So it might be that some shareholders are taking profits after good performance. Only time will tell if there is still too much optimism currently reflected in the share price.With that in mind, it's worth seeing if the company's underlying fundamentals have been the driver of long term performance, or if there are some discrepancies.ASX:OIL Earnings and Revenue Growth October 15th 2024. We're pleased to report that Optiscan Imaging shareholders have received a total shareholder return of 130% over one year. That gain is better than the annual TSR over five years, which is 35%. Therefore it seems like sentiment around the company has been positive lately. Given the share price momentum remains strong, it","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/oY9vQNBdaHAXW3k6VZJztA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/b23fe2923663ce315e2ef7ba313db8b9","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/oY9vQNBdaHAXW3k6VZJztA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/b23fe2923663ce315e2ef7ba313db8b9"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/investing-optiscan-imaging-asx-oil-014023091.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["BK7007","OIL","OIL.AU"],"gpt_icon":0},{"id":"2470650060","title":"Here's Why We're Not Too Worried About Optiscan Imaging's (ASX:OIL) Cash Burn Situation","url":"https://stock-news.laohu8.com/highlight/detail?id=2470650060","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2470650060?lang=en_us&edition=fundamental","pubTime":"2024-09-28 04:38","pubTimestamp":1727469532,"startTime":"0","endTime":"0","summary":"Just because a business does not make any money, does not mean that the stock will go down. By way of example, Optiscan...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-oil/optiscan-imaging-shares/news/heres-why-were-not-too-worried-about-optiscan-imagings-asxoi","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["OIL","BK7007","OIL.AU"],"gpt_icon":0},{"id":"2464343590","title":"We Think Optiscan Imaging (ASX:OIL) Can Afford To Drive Business Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2464343590","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2464343590?lang=en_us&edition=fundamental","pubTime":"2024-09-01 06:51","pubTimestamp":1725144672,"startTime":"0","endTime":"0","summary":"In light of its strong share price run, we think now is a good time to investigate how risky Optiscan Imaging's cash burn is. For the purpose of this article, we'll define cash burn as the amount of cash the company is spending each year to fund its growth . We'll start by comparing its cash burn with its cash reserves in order to calculate its cash runway.While Optiscan Imaging does have a solid cash runway, its cash burn trajectory may have some shareholders thinking ahead to when the company may need to raise more cash. Issuing new shares, or taking on debt, are the most common ways for a listed company to raise more money for its business. One of the main advantages held by publicly listed companies is that they can sell shares to investors to raise cash and fund growth. By comparing a company's annual cash burn to its total market capitalisation, we can estimate roughly how many shares it would have to issue in order to run the company for another year .","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/oY9vQNBdaHAXW3k6VZJztA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/b23fe2923663ce315e2ef7ba313db8b9","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/oY9vQNBdaHAXW3k6VZJztA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/b23fe2923663ce315e2ef7ba313db8b9"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/think-optiscan-imaging-asx-oil-225112623.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["OIL.AU","OIL","BK7007"],"gpt_icon":0},{"id":"2460872249","title":"Optiscan Imaging Signs MoU with University of Minnesota College of Veterinary Medicine","url":"https://stock-news.laohu8.com/highlight/detail?id=2460872249","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2460872249?lang=en_us&edition=fundamental","pubTime":"2024-08-19 10:10","pubTimestamp":1724033444,"startTime":"0","endTime":"0","summary":"Optiscan Imaging  entered into a memorandum of understanding with the University of Minnesota College of Veterinary Medicine to advance research in veterinary medicine, according to a Monday filing with the Australian Securities Exchange.The MoU outlines a research agreement between the parties to trial clinical applications and develop clinical data for the company's digital confocal laser endomicroscopic imaging technology, with an initial focus on improving cancer detection and treatment in companion animals.The planned research and testing aims to gather clinical data for US FDA clearance of the company's imaging platform for veterinary medicine, the filing said.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7007","OIL.AU"],"gpt_icon":0},{"id":"2460722255","title":"Optiscan Imaging Signs MoU with University of Minnesota College of Veterinary Medicine","url":"https://stock-news.laohu8.com/highlight/detail?id=2460722255","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2460722255?lang=en_us&edition=fundamental","pubTime":"2024-08-19 10:10","pubTimestamp":1724033444,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_live","symbols":["OIL.AU","XAO.AU","BK7007","OIL","XKO.AU","XJO.AU"],"gpt_icon":0},{"id":"2455507446","title":"Optiscan Imaging, Partner Complete Beta Testing of Medical Imaging Technology","url":"https://stock-news.laohu8.com/highlight/detail?id=2455507446","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2455507446?lang=en_us&edition=fundamental","pubTime":"2024-07-29 12:35","pubTimestamp":1722227728,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_live","symbols":["OIL.AU","XKO.AU","XJO.AU","OIL","BK7007","XAO.AU"],"gpt_icon":0},{"id":"2455507257","title":"Optiscan Imaging, Partner Complete Beta Testing of Medical Imaging Technology","url":"https://stock-news.laohu8.com/highlight/detail?id=2455507257","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2455507257?lang=en_us&edition=fundamental","pubTime":"2024-07-29 12:35","pubTimestamp":1722227728,"startTime":"0","endTime":"0","summary":"Optiscan Imaging  and partner Prolucid Technologies completed the beta phase of a cloud-based imaging technology for pathologists and clinicians, according to a Monday filing with the Australian bourse.The platform was designed to streamline the telepathology workflow using secure device-to-cloud connectivity and a dedicated web portal, the filing said.Key deliverables in the beta phase include the ability to register, authenticate, and securely connect devices to the cloud platform.\"Our aim is to initially implement a minimal viable telepathology platform, with further enhancements and features to be developed in subsequent phases,\" said Chief Executive Camile Farah.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7007","OIL.AU"],"gpt_icon":0},{"id":"2455506487","title":"Optiscan Imaging completes beta phase testing of cloud-based telepathology platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2455506487","media":"Small Caps","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2455506487?lang=en_us&edition=fundamental","pubTime":"2024-07-29 10:31","pubTimestamp":1722220289,"startTime":"0","endTime":"0","summary":"Commercial-stage medical technology company Optiscan Imaging  has completed beta phase testing of its cloud-based telepathology platform developed in partnership with Prolucid Technologies.The platform is believed to represent a significant advancement in digital pathology, enabling real-time collaboration on patient imaging sessions and allowing remote users to make immediate and informed decisions.The phase tested its functionality and opened the way for enhanced patient imaging in remote scenarios.The new platform leverages Optiscan’s confocal imaging technology to natively generate digital pathology data and empower remote pathologists and clinicians to collaborate in real-time during imaging sessions.“This platform is a potential game-changer for rural and remote patients who have traditionally lacked access to dedicated pathology expertise and immediate decision-making from clinicians and pathologists,” she said.“It demonstrates that we have met our goal of creating a cloud-conne","market":"us","thumbnail":"https://cdn.shortpixel.ai/client/w_868,q_lossy,to_auto,ret_wait/https://150309019.v2.pressablecdn.com/wp-content/uploads/2024/07/Optiscan-Imaging-ASX-OIL-Prolucid-Technologies-platform.jpg","type":0,"news_type":0,"thumbnails":["https://cdn.shortpixel.ai/client/w_868,q_lossy,to_auto,ret_wait/https://150309019.v2.pressablecdn.com/wp-content/uploads/2024/07/Optiscan-Imaging-ASX-OIL-Prolucid-Technologies-platform.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://smallcaps.com.au/optiscan-imaging-beta-testing-cloud-based-telepathology-platform/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"smallcap_stock","symbols":["BK7007","OIL.AU"],"gpt_icon":0},{"id":"2454535177","title":"Meet David: The self-taught trader with 37% returns p.a.","url":"https://stock-news.laohu8.com/highlight/detail?id=2454535177","media":"LiveWire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2454535177?lang=en_us&edition=fundamental","pubTime":"2024-07-26 10:09","pubTimestamp":1721959791,"startTime":"0","endTime":"0","summary":"David isn't spending time meticulously analysing a company's fundamentals before he invests. In fact, his entire portfolio shifts every few days.As a self-professedquant, whose days are a \"brutal study in increasing self-discipline\", David spends his time carefully studying breakouts and pullbacks in trending small and mid-cap ASX-listed shares. There are currently around 300 companies on his watchlist, although he typically only holds 13-17 stocks.It's a far cry from where it all began - a young 19-year-old hooked on the thrill of investing. After university, at 25, David landed a graduate job with Macquarie's investment banking division. He only lasted three weeks, although he hasn't looked back since. Other than those three weeks, he's never had a real job or boss. How many can say the same?While working for yourself and by yourself has its merits, it hasn't been all easy sailing. He's had countless losses, but he's learnt to focus on where he's going rather than dwell in the past.\"","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"livewire_stock","url":"https://www.livewiremarkets.com/wires/meet-david-the-self-taught-trader-with-37-returns-p-a","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.livewiremarkets.com/wires/meet-david-the-self-taught-trader-with-37-returns-p-a","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"livewire_stock","symbols":["WTM.AU","AIM.AU","BK7036","TTT.AU","BK7094","KLI.AU","BK7096","BK7023","ALA.AU","ZIP.AU","CU6.AU","OIL.AU","EGL.AU","BK7064","BK7093","DXB.AU","BK7501","BK7062","AUC.AU","XRF.AU","BK7104","BK7088","TRI.AU","BK7007","BK7508","BPH.AU","TTM.AU","RIM.AU","BK7095","SPR.AU","BK7048","BK7126","BK7067","PNV.AU","SKS.AU","VYS.AU"],"gpt_icon":0},{"id":"2452137981","title":"Optiscan Imaging Insider Ups Holding During Year","url":"https://stock-news.laohu8.com/highlight/detail?id=2452137981","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2452137981?lang=en_us&edition=fundamental","pubTime":"2024-07-18 05:37","pubTimestamp":1721252250,"startTime":"0","endTime":"0","summary":"Looking at Optiscan Imaging Limited's  insider transactions over the last year, we can see that insiders were net buyers. That is, there were more number of shares purchased by insiders than there were sold.While insider transactions are not the most important thing when it comes to long-term investing, logic dictates you should pay some attention to whether insiders are buying or selling shares.Check out our latest analysis for Optiscan Imaging. Optiscan Imaging Insider Transactions Over The Last Year. The insider Robert Peters made the biggest insider purchase in the last 12 months. That single transaction was for AU$1.1m worth of shares at a price of AU$0.084 each. Even though the purchase was made at a significantly lower price than the recent price , we still think insider buying is a positive. Because the shares were purchased at a lower price, this particular buy doesn't tell us much about how insiders feel about the current share price.You can see a visual depiction of insider ","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/oY9vQNBdaHAXW3k6VZJztA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/b23fe2923663ce315e2ef7ba313db8b9","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/oY9vQNBdaHAXW3k6VZJztA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/b23fe2923663ce315e2ef7ba313db8b9"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/optiscan-imaging-insider-ups-holding-213730388.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["BK7007","OIL.AU"],"gpt_icon":0},{"id":"2451870667","title":"BUZZ-Australia's Optiscan Imaging gains on ethical clearance for breast cancer study","url":"https://stock-news.laohu8.com/highlight/detail?id=2451870667","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2451870667?lang=en_us&edition=fundamental","pubTime":"2024-07-15 12:29","pubTimestamp":1721017779,"startTime":"0","endTime":"0","summary":"** Shares of Optiscan Imaging    rise 12.82% to A$0.22, on track for their best day since June 24, if gains hold   ** The imaging technologies maker receives ethical clearance for breast cancer study   ** Co says the study will assess the clinical workflow and real-time imaging capability of its recently unveiled InVue precision surgery imaging platform in breast cancer   ** Stock has doubled gains this year, as of last close ","market":null,"thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OIL.AU","XKO.AU","XJO.AU","BK7007","XAO.AU"],"gpt_icon":0},{"id":"2451650815","title":"Optiscan Imaging Secures Ethics Clearance for Breast Cancer Imaging Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2451650815","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2451650815?lang=en_us&edition=fundamental","pubTime":"2024-07-15 09:44","pubTimestamp":1721007895,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_live","symbols":["XJO.AU","XKO.AU","BK7007","OIL","OIL.AU","XAO.AU"],"gpt_icon":0},{"id":"2451650317","title":"Optiscan Imaging Secures Ethics Clearance for Breast Cancer Imaging Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2451650317","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2451650317?lang=en_us&edition=fundamental","pubTime":"2024-07-15 09:44","pubTimestamp":1721007895,"startTime":"0","endTime":"0","summary":"Optiscan Imaging  secured ethics clearance for the use of its inVue precision surgery imaging platform in patients with breast cancer, according to a filing with the Australian Securities Exchange.The program will test the platform in real-time, validating the removal of tumors during surgery among 50 estimated participants, the medical technology firm said in the filing.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["OIL.AU","BK7007"],"gpt_icon":0},{"id":"2451652491","title":"BRIEF-Optiscan Imaging Got Ethical Clearance For Vivo In-Human Imaging For Breast Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2451652491","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2451652491?lang=en_us&edition=fundamental","pubTime":"2024-07-15 09:25","pubTimestamp":1721006720,"startTime":"0","endTime":"0","summary":"July 15 (Reuters) - Optiscan Imaging Ltd   :   * GOT ETHICAL CLEARANCE TO UNDERTAKE IN VIVO IN-HUMAN IMAGING FOR BREAST CANCERFurther company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","market":null,"thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OIL.AU","BK7007"],"gpt_icon":0},{"id":"2451635655","title":"Optiscan Imaging - Got Ethical Clearance to Undertake in Vivo in-Human Imaging for Breast Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2451635655","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2451635655?lang=en_us&edition=fundamental","pubTime":"2024-07-15 07:04","pubTimestamp":1720998246,"startTime":"0","endTime":"0","summary":"Optiscan Imaging - Got Ethical Clearance to Undertake in Vivo in-Human Imaging for Breast Cancer","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20240714:nFWN3J4157:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7007","OIL.AU"],"gpt_icon":0},{"id":"2450370376","title":"Optiscan Imaging Insiders Land Bargain With Gains Of AU$2.1m","url":"https://stock-news.laohu8.com/highlight/detail?id=2450370376","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2450370376?lang=en_us&edition=fundamental","pubTime":"2024-07-12 10:18","pubTimestamp":1720750703,"startTime":"0","endTime":"0","summary":"Insiders who bought Optiscan Imaging Limited ( ASX:OIL ) stock lover the last 12 months are probably not as affected by...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-oil/optiscan-imaging-shares/news/optiscan-imaging-insiders-land-bargain-with-gains-of-au21m","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7007","OIL.AU","OIL"],"gpt_icon":0},{"id":"2450552093","title":"Four Pharma & Biotech Stocks on the Move in June","url":"https://stock-news.laohu8.com/highlight/detail?id=2450552093","media":"LiveWire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2450552093?lang=en_us&edition=fundamental","pubTime":"2024-07-09 14:58","pubTimestamp":1720508287,"startTime":"0","endTime":"0","summary":"There were three companies in the Pharma & Biotech sector whose share prices rallied 70%+ in June, although share price increases for the sector were relatively muted when compared to the previous month. Below we take a look at four companies whose share prices rallied in June.Actinogen Medical is a biotech company developing a novel therapy for neurological and neuropsychiatric diseases associated with dysregulated brain cortisol. The share price rallied 113.8% in June largely driven by the announcement that the peer reviewed publication of the Phase 2a biomarker trial was published in the Journal of Alzheimer’s Disease.The Company is also trialling the use of Xanamem to improve the cognitive function of patients with major depressive disorder . The Company completed the final patient visit for the Phase 2a XanaCIDD trial in July and expects the results to be available in August 2024. The trial included 167 patients with persistent MDD and measurable cogn","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"livewire_stock","url":"https://www.livewiremarkets.com/wires/four-pharma-biotech-stocks-on-the-move-in-june","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.livewiremarkets.com/wires/four-pharma-biotech-stocks-on-the-move-in-june","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"livewire_stock","symbols":["OIL.AU","BK7048","RAC.AU","BK4183","BK7508","ODD","BK7067","BK7007","ACW.AU","EZZ.AU"],"gpt_icon":0},{"id":"2445249562","title":"Insiders of Optiscan Imaging Limited (ASX:OIL) were rewarded after last week’s 16% gain","url":"https://stock-news.laohu8.com/highlight/detail?id=2445249562","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2445249562?lang=en_us&edition=fundamental","pubTime":"2024-06-21 04:32","pubTimestamp":1718915534,"startTime":"0","endTime":"0","summary":"Insiders appear to have a vested interest in Optiscan Imaging's growth, as seen by their sizeable ownership. A look at the shareholders of Optiscan Imaging Limited  can tell us which group is most powerful. And the group that holds the biggest piece of the pie are individual insiders with 37% ownership. In other words, the group stands to gain the most  from their investment into the company.Having purchased shares recently, insiders must be glad after market cap hit AU$150m last week.Let's delve deeper into each type of owner of Optiscan Imaging, beginning with the chart below.Check out our latest analysis for Optiscan Imaging. ASX:OIL Earnings and Revenue Growth June 20th 2024. Insider ownership is positive when it signals leadershi","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/oY9vQNBdaHAXW3k6VZJztA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/b23fe2923663ce315e2ef7ba313db8b9","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/oY9vQNBdaHAXW3k6VZJztA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/b23fe2923663ce315e2ef7ba313db8b9"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/insiders-optiscan-imaging-limited-asx-203214894.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["OIL.AU","OIL","BK7007"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.optiscan.com","stockEarnings":[{"period":"1week","weight":-0.1765},{"period":"1month","weight":-0.1515},{"period":"3month","weight":-0.2632},{"period":"6month","weight":0.4},{"period":"1year","weight":0.4894},{"period":"ytd","weight":0.6667}],"compareEarnings":[{"period":"1week","weight":0.0042},{"period":"1month","weight":-0.0179},{"period":"3month","weight":-0.0235},{"period":"6month","weight":0.0101},{"period":"1year","weight":0.1386},{"period":"ytd","weight":0.1243}],"compareStock":{"symbol":"F100.AU","name":"BETASHARES FTSE 100 ETF"},"description":"Optiscan Imaging Limited engages in the development and commercialization of confocal endomicroscopic imaging technologies for medical, translational, and pre-clinical applications in Australia, North America, Europe, and Asia. It offers ViewnVivo, a miniaturized fluorescence endomicroscope platform that brings imaging flexibility to preclinical research. The company also provides FIVE2 ViewnVivo system that enables virtual biopsies in living tissue. Optiscan Imaging Limited was founded in 1994 and is headquartered in Mulgrave, Australia.","yearOnYearQuotes":[{"month":1,"riseRate":0.444444,"avgChangeRate":0.045511},{"month":2,"riseRate":0.307692,"avgChangeRate":-0.034897},{"month":3,"riseRate":0.5,"avgChangeRate":0.075595},{"month":4,"riseRate":0.307692,"avgChangeRate":0.057345},{"month":5,"riseRate":0.269231,"avgChangeRate":-0.011956},{"month":6,"riseRate":0.576923,"avgChangeRate":0.068833},{"month":7,"riseRate":0.407407,"avgChangeRate":0.014828},{"month":8,"riseRate":0.357143,"avgChangeRate":0.006572},{"month":9,"riseRate":0.428571,"avgChangeRate":0.024396},{"month":10,"riseRate":0.535714,"avgChangeRate":0.046202},{"month":11,"riseRate":0.296296,"avgChangeRate":0.014573},{"month":12,"riseRate":0.444444,"avgChangeRate":0.012555}],"exchange":"ASX","name":"OPTISCAN IMAGING LIMITED","nameEN":"OPTISCAN IMAGING LIMITED"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"OPTISCAN IMAGING LIMITED(OIL.AU),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest OPTISCAN IMAGING LIMITED(OIL.AU) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"OPTISCAN IMAGING LIMITED,OIL.AU,OPTISCAN IMAGING LIMITED股票,OPTISCAN IMAGING LIMITED股票老虎,OPTISCAN IMAGING LIMITED股票老虎国际,OPTISCAN IMAGING LIMITED行情,OPTISCAN IMAGING LIMITED股票行情,OPTISCAN IMAGING LIMITED股价,OPTISCAN IMAGING LIMITED股市,OPTISCAN IMAGING LIMITED股票价格,OPTISCAN IMAGING LIMITED股票交易,OPTISCAN IMAGING LIMITED股票购买,OPTISCAN IMAGING LIMITED股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"OPTISCAN IMAGING LIMITED(OIL.AU),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest OPTISCAN IMAGING LIMITED(OIL.AU) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction